Prognostic significance of miR-194 in endometrial cancer

Zhai, Haiyan; Karaayvaz, Mihriban; Dong, Peixin; Sakuragi, Noriaki; Ju, Jingfang

doi:10.1186/2050-7771-1-12


Hokkaido University \| Library \| HUSCAP	Advanced Search		言語

	Home
	About HUSCAP
	Open Access Policy

	Browse by Author

Browse
	Communities & Collections

	Scholarly Journals
	Theses
	Doctoral Dissertations Listed by Graduate Schools
	Conference Procs.
	Events

	HUSCAP Senior (in Japanese)

	Societies

	Downloads (country)

For university staff
	How to post your papers to HUSCAP
	Publication of theses
	Helpline about theses publication

Open Archives Compliant

You can search our collection also at:
	Google
	Google Scholar
	CiNii
	IRDB
	OAIster
	NDLTD

Hokkaido University Collection of Scholarly and Academic Papers >
Graduate School of Medicine / Faculty of Medicine >
Peer-reviewed Journal Articles, etc >

Prognostic significance of miR-194 in endometrial cancer

This item is licensed under:Creative Commons Attribution 2.0 Generic

Files in This Item:

6.pdf

261.4 kB

PDF

View/Open

Please use this identifier to cite or link to this item:http://hdl.handle.net/2115/60535

Title:	Prognostic significance of miR-194 in endometrial cancer
Authors:	Zhai, Haiyan Browse this author
	Karaayvaz, Mihriban Browse this author
	Dong, Peixin Browse this author
	Sakuragi, Noriaki Browse this author →KAKEN DB
	Ju, Jingfang Browse this author
Keywords:	MiR-194
Keywords:	Endometrial cancer
Issue Date:	18-Feb-2013
Publisher:	BioMed Central
Journal Title:	Biomarker Research
Volume:	1
Issue:	1
Start Page:	12
Publisher DOI:	10.1186/2050-7771-1-12
Abstract:	Endometrial cancer (EC) is the leading malignant tumor occurring in the female genital tract and some subtypes are highly invasive and metastatic. miRNAs are small non-coding RNAs that have a broad impact on cancer progression. In particular, miR-194 regulates epithelial to mesenchymal transition (EMT) by suppressing the expression of BMI-1 in EC. In this retrospective study, the clinical significance of miR-194 was investigated in archival EC specimens. We extracted total RNA from thirty-two EC samples and quantified the expression level of miR-194. We discovered that the expression level of miR-194 was significantly (P = 0.03) lower in type I EC patients with more advanced stage. In addition, patients with higher miR-194 levels have better prognosis than those with lower miR-194 levels (P = 0.0067; Cut-off value of miR-194 = 0.3). These results indicate that miR-194 has potential to serve as prognostic biomarker for EC patients.
Rights:	http://creativecommons.org/licenses/by/2.0/
Type:	article
URI:	http://hdl.handle.net/2115/60535
Appears in Collections:	医学院・医学研究院 (Graduate School of Medicine / Faculty of Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

Submitter: 董培新

OAI-PMH ( junii2 , jpcoar_1.0 )

- Hokkaido University